{
	"resourceType": "ResearchStudy",
	"id": "ResearchStudy2858",
	"meta": {
		"versionId": "1",
		"lastUpdated": "2021-07-27T19:52:16.969+00:00",
		"source": "#tXPaGcdH4FU5ZaYY"
	},
	"contained": [
		{
			"resourceType": "PlanDefinition",
			"id": "plan_definition-2857",
			"status": "draft"
		},
		{
			"resourceType": "Practitioner",
			"id": "practitioner-2857",
			"name": [
				{
					"use": "official",
					"text": "John Doe, IV, MD",
					"family": "Doe",
					"given": [
						"John"
					],
					"suffix": [
						"IV",
						"MD"
					]
				}
			]
		}
	],
	"identifier": [
		{
			"use": "usual",
			"type": {
				"text": "The Questionnaire Response ID for the associated Initiate a Study FHIR Questionnaire Response"
			},
			"system": "https://www.example-fhir-server.com/hapi-fhir-jpaserver/fhir/QuestionnaireResponse",
			"value": "QRID-2857"
		},
		{
			"use": "usual",
			"type": {
				"text": "IRB Study Protocol Number assigned by the sIRB's IRB study database"
			},
			"value": "SUMC-1234567",
			"assigner": {
				"display": "Sample University Medical Center(SUMC)"
			}
		}
	],
	"title": "Double blind, placebo-controlled trial of a new class of arthritis medication",
	"protocol": [
		{
			"reference": "#plan_definition-2857"
		}
	],
	"status": "in-review",
	"category": [
		{
			"text": "Interventional"
		}
	],
	"keyword": [
		{
			"text": "NIH-2021-123456"
		}
	],
	"principalInvestigator": {
		"reference": "#practitioner-2857"
	}
}